Access cutting-edge hepatobiliary cancers treatment through this clinical trial at a research site in Mobile. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Mobile location
Preparing your pre-screening questions…
Access hepatobiliary cancers specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hepatobiliary cancers treatment provided free
Check if you qualify for this hepatobiliary cancers clinical trial in Mobile, AL
No-Cost Study Care
Local to Mobile
Convenient for AL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Given the number of anticipated durvalumab-based treatment launches in the hepatobiliary cancer space over the next 3 years, there is a need to capture contemporary real-world data across these indications. LIVER-R is a multicountry, multicenter, observational study of patients with a confirmed diagnosis of hepatobiliary cancer treated with a durvalumab-based regimen as part of routine clinical practice or early access program (EAP). The study design will include primary and secondary data collection. The primary objective of this study is to evaluate the effectiveness of durvalumab-based regimens in real-world settings as measured by real-world overall survival. Other endpoints include demographics, clinical characteristics, clinically significant events of interest, treatment patterns, concomitant medications, and other real-world clinical endpoints (such as duration of treatment, progression-free survival, time to treatment progression, time to next treatment, recurrence-free survival, and time to treatment recurrence).
Sponsor: AstraZeneca
Yes, this clinical trial (NCT06252753) has an active research site in Mobile, AL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for hepatobiliary cancers treatment options in Mobile, AL, this clinical trial (NCT06252753) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Mobile research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hepatobiliary cancers specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.